Prashant Rajbhandari, PhD
img_Prashant Rajbhandari
ASSISTANT PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Research Topics
Adipose, Diabetes, Metabolism
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT)
New topic
Rajbhandari Lab is broadly interested in 1) Immune cell regulation of lipid metabolism, 2) developmental process of brown/beige and white fat, and 3) crosstalk between adipose and other metabolic tissues (esp. liver) in the setting of obesity. To address these topics, the lab uses cell and molecular biology, biochemistry, next-gen sequencing (ChIP-, RNA-, ATAC-seq), animal model, single cell/nuclei RNA sequencing, and imaging. The lab seeks to further advance the understanding of human adiposity in collaboration with St. Luke’s Hospital. The broader significance of the work in Rajbhandari Lab is that obesity is linked to various diseases and by studying how cellular and molecular pathways are perturbed in the setting of obesity might provide better understanding of this disease. Visit the Rajbhandari Lab

BA, Olivet College

PhD, University of Wisconsin

Postdoc, University of California-Los Angeles ; Howard Hughes Medical Institute

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Rajbhandari has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.